Position in ANAB
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$39,424,725
+$20,970,816 QoQ
Shares Held
584,070
+17.0% QoQ
Ownership
2.01%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#13
of 211 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ANAB Over Time
Shares Held
Position Value (USD)
Derivatives in ANAB
reported options exposure · as of Jun 30, 2021CallValue
$0
CallShares
0
PutValue
$666,402
PutShares
38,550
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026GOLDMAN SACHS GROUP INC holds $13,040,376,854 across 359 Biotechnology names. ANAB ranks #78 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,481,761 | $1,232,765,138 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,163,191 | $725,296,113 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
18,556,458 | $656,713,046 | |
| 4 | TECH |
BIO-TECHNE Corp
|
7,343,324 | $518,805,838 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
2,133,101 | $399,487,154 | |
| 6 | MRNA |
Moderna, Inc.
|
4,671,950 | $327,176,656 | |
| 7 | TNGX |
Tango Therapeutics, Inc.
|
9,980,620 | $311,994,180 | |
| 8 | INCY |
Incyte Corp
|
2,305,782 | $261,383,446 |
All Filings in ANAB
Export CSV
28 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $39,424,725 | 584,070 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $18,453,909 | 332,743 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $19,339,350 | 398,914 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $10,099,070 | 329,820 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $6,212,336 | 279,835 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $5,215,911 | 280,577 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $5,548,983 | 419,106 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $11,737,176 | 350,364 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $4,875,156 | 194,539 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $3,387,698 | 150,431 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $2,988,110 | 139,501 | Shares | Defined | 2024-05-14 | |
| 2023-09-30 | $3,204,072 | 178,401 | Shares | Defined | 2024-05-15 | |
| 2023-06-30 | $2,685,612 | 132,036 | Shares | Defined | 2024-05-14 | |
| 2023-03-31 | $4,038,665 | 185,600 | Shares | Defined | 2024-05-14 | |
| 2022-12-31 | $3,333,748 | 107,575 | Shares | Defined | 2024-05-14 | |
| 2022-09-30 | $2,451,208 | 96,088 | Shares | Defined | 2024-05-14 | |
| 2022-06-30 | $2,291,031 | 112,859 | Shares | Defined | 2024-05-14 | |
| 2022-03-31 | $5,686,056 | 229,833 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $11,024,001 | 317,237 | Shares | Defined | 2022-02-17 | |
| 2021-09-30 | $9,427,508 | 347,622 | Shares | Defined | 2022-01-20 | |
| 2021-06-30 | $8,161,716 | 314,759 | Shares | Defined | 2021-08-13 | |
| 2021-06-30 | $666,402 | 25,700 | Put | Defined | 2021-08-13 | |
| 2021-03-31 | $9,202,990 | 427,052 | Shares | Defined | 2021-05-17 | |
| 2021-03-31 | $553,836 | 25,700 | Put | Defined | 2021-05-17 | |
| 2020-12-31 | $7,391,919 | 343,811 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $3,889,428 | 263,691 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $7,688,650 | 344,166 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $1,502,824 | 106,357 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||